You just read:

Surveyed U.S. Physicians and Hospital Pharmacy Directors Cite Ofirmev's Ability to Reduce Postoperative Opioid Use as the Primary Factor Influencing Prescribing and Coverage

News provided by

Decision Resources Group

Apr 29, 2014, 01:00 ET